- REGN has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $390.3 million.
- REGN traded 10,524 shares today in the pre-market hours as of 7:49 AM.
- REGN is down 4.1% today from Friday's close.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in REGN with the Ticky from Trade-Ideas. See the FREE profile for REGN NOW at Trade-Ideas More details on REGN: Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. REGN has a PE ratio of 166. Currently there are 12 analysts that rate Regeneron Pharmaceuticals a buy, no analysts rate it a sell, and 7 rate it a hold. The average volume for Regeneron Pharmaceuticals has been 817,200 shares per day over the past 30 days. Regeneron has a market cap of $52.5 billion and is part of the health care sector and drugs industry. The stock has a beta of 0.71 and a short float of 5.9% with 5.60 days to cover. Shares are up 31.5% year-to-date as of the close of trading on Friday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.